Details for New Drug Application (NDA): 202519
✉ Email this page to a colleague
The generic ingredient in VALSARTAN AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; valsartan. There are thirty-two drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; valsartan profile page.
Summary for 202519
Tradename: | VALSARTAN AND HYDROCHLOROTHIAZIDE |
Applicant: | Aurobindo Pharma Ltd |
Ingredient: | hydrochlorothiazide; valsartan |
Patents: | 0 |
Pharmacology for NDA: 202519
Mechanism of Action | Angiotensin 2 Receptor Antagonists |
Physiological Effect | Increased Diuresis |
Suppliers and Packaging for NDA: 202519
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VALSARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; valsartan | TABLET;ORAL | 202519 | ANDA | Proficient Rx LP | 63187-312 | 63187-312-30 | 30 TABLET, FILM COATED in 1 BOTTLE (63187-312-30) |
VALSARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; valsartan | TABLET;ORAL | 202519 | ANDA | Proficient Rx LP | 63187-312 | 63187-312-90 | 90 TABLET, FILM COATED in 1 BOTTLE (63187-312-90) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 12.5MG;80MG | ||||
Approval Date: | Mar 21, 2013 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 12.5MG;160MG | ||||
Approval Date: | Mar 21, 2013 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 12.5MG;320MG | ||||
Approval Date: | Mar 21, 2013 | TE: | AB | RLD: | No |
Complete Access Available with Subscription